1995
DOI: 10.1016/s0065-2725(08)60473-0
|View full text |Cite
|
Sign up to set email alerts
|

Recent Developments in the Chemistry of Pyrido[1,2-a]pyrimidines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1996
1996
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(3 citation statements)
references
References 281 publications
0
3
0
Order By: Relevance
“…1 H NMR spectra were recorded on a Varian 400 spectrometer in DMSO-d 6 as a solvent and TMS as an internal standard. Peak values are shown in d ppm.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…1 H NMR spectra were recorded on a Varian 400 spectrometer in DMSO-d 6 as a solvent and TMS as an internal standard. Peak values are shown in d ppm.…”
Section: Methodsmentioning
confidence: 99%
“…This is evident, in particular, from publications of regular reviews on the chemistry of systems where the pyrimidine ring is fused to various heterocycles, such as, purines [1], pteridines [2], quinazolines [3], pyridopyrimidines [4,5], triazolopyrimidines [6], pyrazolopyrimidines [7], pyrimidoazepines [8], furopyrimidines, and pyrrolopyrimidines. Thienopyrimidines occupy a special position among these compounds.…”
Section: Introductionmentioning
confidence: 99%
“…The N-bridged heterocycles containing nitrogen atom common to two rings, particularly fused heterosystems, have been the subject of great concern in the chemical research not only from the theoretical point of view, but also for the preparation of potential pharmaceuticals [1][2][3][4][5][6][7][8][9][10]. In view of the structural diversity and pharmacological significance of N-bridged heterocycles resulting in the fusion of two biodynamic heterosystems and our continuing efforts of synthesizing especially nitrogen-and sulfur-containing heterocycles of potential therapeutic interest [11][12][13], we have synthesized novel bioactive heterocycles, 2-methyl-4H-pyrimido [2,1-b]benzothiazol-4-ones, which involve the structural fusion of two structurally as well pharmacologically interesting heterocyclic systems [14][15][16]; benzothiazole and pyrimidine.…”
Section: Introductionmentioning
confidence: 99%